PL139646B1 - Process for preparing novel 5-/substituted phenyl/-hydantoins - Google Patents

Process for preparing novel 5-/substituted phenyl/-hydantoins Download PDF

Info

Publication number
PL139646B1
PL139646B1 PL1983244350A PL24435083A PL139646B1 PL 139646 B1 PL139646 B1 PL 139646B1 PL 1983244350 A PL1983244350 A PL 1983244350A PL 24435083 A PL24435083 A PL 24435083A PL 139646 B1 PL139646 B1 PL 139646B1
Authority
PL
Poland
Prior art keywords
formula
compounds
sodium
solution
ether
Prior art date
Application number
PL1983244350A
Other languages
English (en)
Polish (pl)
Other versions
PL244350A1 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL244350A1 publication Critical patent/PL244350A1/xx
Publication of PL139646B1 publication Critical patent/PL139646B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72Two oxygen atoms, e.g. hydantoin
    • C07D233/76Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL1983244350A 1982-11-01 1983-10-28 Process for preparing novel 5-/substituted phenyl/-hydantoins PL139646B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/438,199 US4452806A (en) 1982-11-01 1982-11-01 Treating diabetic complications with 5-(substituted phenyl)hydantoins

Publications (2)

Publication Number Publication Date
PL244350A1 PL244350A1 (en) 1985-02-13
PL139646B1 true PL139646B1 (en) 1987-02-28

Family

ID=23739660

Family Applications (1)

Application Number Title Priority Date Filing Date
PL1983244350A PL139646B1 (en) 1982-11-01 1983-10-28 Process for preparing novel 5-/substituted phenyl/-hydantoins

Country Status (13)

Country Link
US (1) US4452806A (2)
JP (1) JPS5998063A (2)
KR (1) KR860001507B1 (2)
CA (1) CA1203241A (2)
DK (1) DK158724C (2)
ES (1) ES526841A0 (2)
FI (1) FI80265C (2)
GR (1) GR79638B (2)
HU (1) HU191887B (2)
PL (1) PL139646B1 (2)
PT (1) PT77578A (2)
YU (1) YU43556B (2)
ZA (1) ZA838092B (2)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002027786A1 (en) 2000-09-25 2002-04-04 Ibiden Co., Ltd. Semiconductor element, method of manufacturing semiconductor element, multi-layer printed circuit board, and method of manufacturing multi-layer printed circuit board
IT1319201B1 (it) * 2000-10-12 2003-09-26 Nicox Sa Farmaci per il diabete.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2814256A1 (de) * 1977-04-05 1978-10-12 Ciba Geigy Ag Schmieroelzusatzstoffe
FR2458546A1 (fr) * 1979-06-07 1981-01-02 Hoechst France Procede de fabrication d'aryl-5 hydantoines racemiques et produits nouveaux en resultant

Also Published As

Publication number Publication date
DK158724B (da) 1990-07-09
PT77578A (en) 1983-11-01
ZA838092B (en) 1985-06-26
YU216783A (en) 1986-02-28
ES8507119A1 (es) 1985-05-01
CA1203241A (en) 1986-04-15
HU191887B (en) 1987-04-28
GR79638B (2) 1984-10-31
FI80265B (fi) 1990-01-31
DK158724C (da) 1990-11-19
KR860001507B1 (ko) 1986-09-30
FI833993A7 (fi) 1984-05-02
PL244350A1 (en) 1985-02-13
YU43556B (en) 1989-08-31
ES526841A0 (es) 1985-05-01
US4452806A (en) 1984-06-05
DK499983A (da) 1984-05-02
JPS5998063A (ja) 1984-06-06
FI80265C (fi) 1990-05-10
DK499983D0 (da) 1983-11-01
KR840006630A (ko) 1984-12-01
FI833993A0 (fi) 1983-10-31
JPH0465832B2 (2) 1992-10-21

Similar Documents

Publication Publication Date Title
US4198421A (en) Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles
EP1501504A1 (en) 1-substituted imidazole derivatives as nos inhibitors
HU211947A9 (en) 7-(2-aminoethyl)-benzothiazolones
GB2140412A (en) Thiazolidine derivatives, process for the preparation and pharmaceutical compositions thereof
CN112430221B (zh) 用于预防、治疗或减轻高尿酸血症或痛风的化合物及其应用
US5859036A (en) 3,4-diarylthiazolin-2-one or -2-thione derivatives, their methods of preparation and their uses in their methods of preparation and their uses in therapeutics
US4259344A (en) Sulfur-containing benzimidazole derivatives
US20250127789A1 (en) Compositions useful for modulating splicing
JPS6052157B2 (ja) スピロ−多環式イミダゾリジンジオン誘導体
PT92180B (pt) Processo para a preparacao de novas mevalonolactonas do tipo tienopiridina e de composicoes farmaceuticas que as contem
US4284642A (en) 1,3-Diaryl-2-imino-imidazolidines and compositions thereof
CA1269389A (en) PROCESS FOR PREPARING .gamma.-BUTYROLACTONE DERIVATIVES, AND IMMUNOMODULATING COMPOSITIONS CONTAINING THE SAME AS ACTIVE INGREDIENTS
FI87460C (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 7-fenyl-, naftyl- och bensofuranylisotiazolo/4,5-d/-1,2,3-triazin-4(3h)-oner
US5571825A (en) Method of selectively inhibiting prostaglandin G/H synthase-2
JP2520161B2 (ja) アルコキシ基もしくはベンジルオキシ基またはベンジルチオ基で置換されたジ―t―ブチルフェノ―ル
EP0335979A1 (en) Thienopyrimidine derivatives
CA1150250A (en) Hydantoin derivatives
PL147397B1 (en) Method of obtaining novel derivatives of spiro imidazolidine
US5326883A (en) Oxime ether derivatives having lipoxygenase inhibitory activity
FI58775C (fi) Foerfarande foer framstaellning av vid terapi av ledgaongsreumatism anvaendbart 3,4alfa-di-0-isopropyliden-derivat av 2-metyl-3-hydroxi-4-hydroximetyl-5-merkaptometylpyridin-n-oxid
GB2192002A (en) Glycine derivatives
NZ198192A (en) 1-substituted-1h-tetrazol-5-amines and pharmaceutical compositions
KR860001507B1 (ko) 5-(치환된 페닐) 히단토인의 제조방법
US4882340A (en) Benzofuran derivative and processes for preparing the same
AU610629B2 (en) Improvements in or relating to leukotriene antagonists